Published in Aust N Z J Psychiatry on July 03, 2012
Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med (2015) 1.55
Achieving smoke-free mental health services: lessons from the past decade of implementation research. Int J Environ Res Public Health (2013) 0.93
Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychol Med (2013) 0.91
Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS One (2013) 0.86
What is the role of lifestyle behaviour change associated with non-communicable disease risk in managing musculoskeletal health conditions with special reference to chronic pain? BMC Musculoskelet Disord (2015) 0.80
Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment. Front Hum Neurosci (2016) 0.78
Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis. World Psychiatry (2014) 0.78
Evaluation of somatic health care practices in psychiatric inpatient wards. Aust N Z J Psychiatry (2013) 0.76
Do Physiotherapists Have the Skill to Engage in the "Psychological" in the Bio-Psychosocial Approach? Physiother Can (2016) 0.75
Cardiometabolic risk factors in people with psychotic disorders: the second Australian survey of psychosis: going back to the foundations. Aust N Z J Psychiatry (2012) 0.75
Use of an electronic metabolic monitoring form in a mental health service - a retrospective file audit. BMC Psychiatry (2016) 0.75
Obesity and Serious Mental Ill Health: A Critical Review of the Literature. Healthcare (Basel) (2014) 0.75
A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population. J Nutr Sci (2015) 0.75
Australian Nurse Practitioner Practice: Value Adding through Clinical Reflexivity. Nurs Res Pract (2015) 0.75
Risk Factors for Obstructive Sleep Apnea Are Prevalent in People with Psychosis and Correlate with Impaired Social Functioning and Poor Physical Health. Front Psychiatry (2016) 0.75
Physiotherapy Students' Attitudes toward Psychiatry and Mental Health: A Cross-Sectional Study. Physiother Can (2016) 0.75
Physical Health and Drug Safety in Individuals with Schizophrenia. Can J Psychiatry (2017) 0.75
Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson disease. Clin Auton Res (2015) 0.75
The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36
Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J (2010) 4.31
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat (2005) 4.14
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol (2003) 3.58
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J (2013) 3.58
Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Ann Emerg Med (2012) 3.40
Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust (2012) 3.14
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology. J Am Acad Child Adolesc Psychiatry (2006) 2.62
What do childhood anxiety disorders predict? J Child Psychol Psychiatry (2007) 2.47
The law of attrition revisited. J Med Internet Res (2006) 2.21
Why are community psychiatry services in Australia doing it so hard? Med J Aust (2007) 2.06
Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates. Psychiatry Res (2008) 2.02
Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry (2013) 2.02
Advanced paternal age is associated with impaired neurocognitive outcomes during infancy and childhood. PLoS Med (2009) 1.89
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin Sci (Lond) (2008) 1.85
Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol (2012) 1.80
Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab (2012) 1.70
The YouthMood Project: a cluster randomized controlled trial of an online cognitive behavioral program with adolescents. J Consult Clin Psychol (2009) 1.65
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem (2002) 1.63
Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr (2002) 1.62
Focal adhesion dynamics are altered in schizophrenia. Biol Psychiatry (2013) 1.61
Quality of life of adolescents with cerebral palsy: perspectives of adolescents and parents. Dev Med Child Neurol (2009) 1.59
1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett (2003) 1.59
Revisiting the metabolic syndrome. Med J Aust (2006) 1.58
A new phenomenological survey of auditory hallucinations: evidence for subtypes and implications for theory and practice. Schizophr Bull (2012) 1.58
Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies. Clin Sci (Lond) (2004) 1.58
Advanced paternal and grandpaternal age and schizophrenia: a three-generation perspective. Schizophr Res (2011) 1.57
Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech (2010) 1.57
Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Int J Radiat Oncol Biol Phys (2009) 1.55
The association between delusional-like experiences, and tobacco, alcohol or cannabis use: a nationwide population-based survey. BMC Psychiatry (2011) 1.54
Variance of gene expression identifies altered network constraints in neurological disease. PLoS Genet (2011) 1.53
People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust N Z J Psychiatry (2012) 1.53
The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect (2007) 1.50
Psychopathology in young people with intellectual disability. JAMA (2006) 1.48
Trends in pre-existing mental health disorders among parents of infants born in Western Australia from 1990 to 2005. Med J Aust (2013) 1.45
Mindfulness training: an adjunctive role in the management of chronic illness? Med J Aust (2012) 1.44
A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull (2012) 1.43
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo. Clin Endocrinol (Oxf) (2006) 1.42
Familial hypercholesterolaemia: a look back, a look ahead. Med J Aust (2005) 1.41
n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease. J Hypertens (2015) 1.39
Bipolar disorder: new understandings, emerging treatments. Med J Aust (2010) 1.38
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J Clin Endocrinol Metab (2007) 1.38
On reducing cardiovascular disease to a rarity: clinical strategies and their cost-effectiveness. Heart Lung Circ (2010) 1.38
One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology (2004) 1.35
Layer upon layer: thermoregulation in schizophrenia. Schizophr Res (2004) 1.33
Paediatric quality of life instruments: a review of the impact of the conceptual framework on outcomes. Dev Med Child Neurol (2006) 1.33
A review of psychosocial outcomes for patients seeking cosmetic surgery. Plast Reconstr Surg (2004) 1.33
Validity of the mental health component scale of the 12-item Short-Form Health Survey (MCS-12) as measure of common mental disorders in the general population. Psychiatry Res (2007) 1.33
Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diab Vasc Dis Res (2007) 1.31
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care (2010) 1.29
Laser-driven shock experiments on precompressed water: Implications for "icy" giant planets. J Chem Phys (2006) 1.28
Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol (2012) 1.24
Cohort profile: the PATH through life project. Int J Epidemiol (2011) 1.21
Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med Sci Monit (2003) 1.20
How do obese individuals perceive and respond to the different types of obesity stigma that they encounter in their daily lives? A qualitative study. Soc Sci Med (2011) 1.18
Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav Brain Res (2005) 1.18
Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab (2011) 1.15
MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? Expert Opin Ther Targets (2007) 1.15
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism (2002) 1.14
Internet-based CBT for depression with and without telephone tracking in a national helpline: randomised controlled trial. PLoS One (2011) 1.14
Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis (2003) 1.14
Effects of vitamin D supplementation on cognitive and emotional functioning in young adults--a randomised controlled trial. PLoS One (2011) 1.14
Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res (2006) 1.13
The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol (2011) 1.13
Internet-based interventions to promote mental health help-seeking in elite athletes: an exploratory randomized controlled trial. J Med Internet Res (2012) 1.13
The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Circulation (2015) 1.13
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs (2004) 1.11
Coordinated analysis of age, sex, and education effects on change in MMSE scores. J Gerontol B Psychol Sci Soc Sci (2012) 1.10
Effects on parental mental health of an education and skills training program for parents of young children with autism: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry (2006) 1.10
Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). Patient Educ Couns (2006) 1.10
Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res (2005) 1.10
Psychometric properties of the quality of life questionnaire for children with CP. Dev Med Child Neurol (2007) 1.09
Web-based cognitive behavior therapy for depression with and without telephone tracking in a national helpline: secondary outcomes from a randomized controlled trial. J Med Internet Res (2012) 1.09
Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res (2004) 1.09
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. Diabetes (2002) 1.09
The brain reserve hypothesis, brain atrophy and aging. Gerontology (2006) 1.09
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis (2005) 1.07
Internet-delivered interpersonal psychotherapy versus internet-delivered cognitive behavioral therapy for adults with depressive symptoms: randomized controlled noninferiority trial. J Med Internet Res (2013) 1.07
Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab (2009) 1.07
Autism risk across generations: a population-based study of advancing grandpaternal and paternal age. JAMA Psychiatry (2013) 1.07
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am J Clin Nutr (2006) 1.05
Evidence of altered prefrontal-thalamic circuitry in schizophrenia: an optimized diffusion MRI study. Neuroimage (2006) 1.05
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Arterioscler Thromb Vasc Biol (2006) 1.05
Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans. J Lipid Res (2006) 1.05
Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci Lett (2009) 1.05
Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: An animal model of schizophrenia. Biol Psychiatry (2006) 1.05
Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Med J Aust (2013) 1.04
The voices acceptance and action scale (VAAS): Pilot data. J Clin Psychol (2007) 1.04
The association between delusional-like experiences and suicidal thoughts and behaviour. Schizophr Res (2011) 1.04
High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics. J Clin Endocrinol Metab (2005) 1.03
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma. J Lipid Res (2006) 1.03
Statistical treatment of withdrawal in trials of anti-dementia drugs. Lancet (2008) 1.02
Maternal age and paternal age are associated with distinct childhood behavioural outcomes in a general population birth cohort. Schizophr Res (2009) 1.02
Maternal vitamin D depletion alters neurogenesis in the developing rat brain. Int J Dev Neurosci (2007) 1.02
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care (2009) 1.02